Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:50 AM UTC
| NCT Number | NCT06790693 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 450 participants |
| Active Locations | 62 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT06790693 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 62 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06790693 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 62 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06790693 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.